While sulfonylureas may increase the risk of hypoglycemia and mortality when combined with insulin, metformin enhances insulin sensitivity, and DPP-4 inhibitors have shown protective effects against stroke [15,16]. The gene discussed is INS; the disease is Hypoglycemia.